China announces 16 vaccines in clinical trials

China’s recent Wuhan pneumonia (novel coronavirus disease, COVID-19) new Epidemic serious, China’s vaccine developed and exploded insufficient protection; official has now announced that the existing 16 vaccines into clinical trials, Chinese netizens alarmed: “What is happening?”

Our central epidemic commander Chen Shizhong pointed out in a press conference yesterday that the Chinese vaccine was exposed to opaque information and insufficient protection. The third vaccine has been reported to have 79% protection, but there is not enough information on the young age group above 16 years old and the age group above 59 years old cannot be vaccinated, and the other 60% of the population will only have about 48% herd protection even if they are fully vaccinated.

According to the Chinese official media “China News Agency”, Wu Yuanbin, director of the Department of Social Development Science and Technology of China’s Ministry of Science and Technology, said yesterday (30) at the first China Blood Sciences Development Conference: “At present, 16 new coronavirus vaccines have entered clinical trials in China, of which 7 new coronavirus vaccines have entered Phase III clinical trials and 1 vaccine has been conditionally marketed. ” It was confirmed that China is still initiating several vaccine development operations.

After the news was revealed on Chinese microblogs, some Chinese netizens praised the official action, but also immediately shocked many Chinese netizens, who left comments saying, “The vaccine is ineffective? Why are so many vaccines being developed?”, “We need 16 more shots to be immunized”, “There are too many, this ….. All of them are variant vaccines?” The company’s main goal is to provide the best possible service to its customers. The number of successful cases is very high.